NASDAQ:LOGC - LogicBio Therapeutics Price Target & Analyst Ratings

$11.69
+0.35 (+3.09 %)
(As of 09/15/2019 09:11 AM ET)
Today's Range
$11.51
Now: $11.69
$12.21
50-Day Range
$6.97
MA: $10.21
$12.94
52-Week Range
$6.34
Now: $11.69
$20.07
Volume24,428 shs
Average Volume27,537 shs
Market Capitalization$262.91 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

LogicBio Therapeutics (NASDAQ:LOGC) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for LogicBio Therapeutics in the last 12 months. Their average twelve-month price target is $24.00, suggesting that the stock has a possible upside of 105.30%. The high price target for LOGC is $26.00 and the low price target for LOGC is $20.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $24.00$24.00$24.00$23.3333
Price Target Upside: 105.30% upside199.63% upside70.82% upside70.07% upside

LogicBio Therapeutics (NASDAQ:LOGC) Consensus Price Target History

LogicBio Therapeutics (NASDAQ:LOGC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/15/2019Chardan CapitalReiterated RatingBuy$20.00Medium
5/1/2019Roth CapitalInitiated CoverageBuy ➝ Buy$26.00Medium
11/13/2018BarclaysInitiated CoverageOverweight ➝ Overweight$24.00Low
11/13/2018William BlairInitiated CoverageOutperform ➝ Outperform$26.00Low
(Data available from 9/15/2017 forward)
This page was last updated on 9/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel